Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells
about
S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.Glucose and fatty acid metabolism in a 3 tissue in-vitro model challenged with normo- and hyperglycaemiaThe role of protein kinase C isoforms in insulin action.Advanced glycation end products and oxidative stress in type 2 diabetes mellitus.Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liverIGF-1 mediated phosphorylation of specific IRS-1 serines in Ames dwarf fibroblasts is associated with longevityMechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes.Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cellsIn skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs.Differential impact of flavonoids on redox modulation, bioenergetics and cell signalling in normal and tumor cells: a comprehensive review.Three Peptides from Soy Glycinin Modulate Glucose Metabolism in Human Hepatic HepG2 Cells.Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.Stimulation of glucose uptake and improvement of insulin resistance by aromadendrin.SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.Iron and insulin resistance.Insulin receptor substrate-2-dependent interleukin-4 signaling in macrophages is impaired in two models of type 2 diabetes mellitus.Cocoa flavonoids protect hepatic cells against high-glucose-induced oxidative stress: relevance of MAPKs.Glycogen synthase kinase 3 beta mediates high glucose-induced ubiquitination and proteasome degradation of insulin receptor substrate 1.Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55.Shp2 is required for protein kinase C-dependent phosphorylation of serine 307 in insulin receptor substrate-1.Combination Treatment of Deep Sea Water and Fucoidan Attenuates High Glucose-Induced Insulin-Resistance in HepG2 Hepatocytes.Modulation of cellular glucose metabolism in human HepG2 cells by combinations of structurally related flavonoids.Iron Deprivation May Enhance Insulin Receptor and Glut4 Transcription in Skeletal Muscle of Adult Rats.Sequential cleavage of insulin receptor by calpain 2 and γ-secretase impairs insulin signalling.Tartary buckwheat flavonoids protect hepatic cells against high glucose-induced oxidative stress and insulin resistance via MAPK signaling pathways.Differential Response of Human Hepatocyte Chromatin to HDAC Inhibitors as a Function of Microenvironmental Glucose Level.Cocoa flavonoids improve insulin signalling and modulate glucose production via AKT and AMPK in HepG2 cells.
P2860
Q24309036-01021F92-FFC1-4BE8-B51D-578EB8A72DC8Q33855046-157795C2-D111-4A0E-86EF-D81636725154Q34235400-F5D90FE5-1FB0-4B4C-8C9F-000DA2A1A8D4Q34297658-85231D49-0438-4D5E-A1F8-5AA60DD90D3EQ35255473-1E3C72D1-E9DD-4CF9-B9C5-7452A900F524Q36482256-0AE5C39E-65D9-4BEE-B9D7-297EA017D426Q36546338-ABC06432-0CAC-4ECA-AB6F-4B5DEAF94E76Q36575450-C4F25460-5F68-4A4F-9A3C-27C51BC1C9D6Q36711111-59E2DEA0-5B3E-418F-AE05-E58BA55EFF78Q37142827-C6950BB0-BDCC-4023-8641-4BAB082102F8Q38616035-EB86BE2A-3238-43A6-9852-945FF42CBC14Q38818701-63F84813-356C-47A0-BB38-D38AD122CBB5Q39218780-7D14D71E-2578-4070-BADA-DBF95B8DB709Q39447694-941DC2E2-177F-4685-B114-852088D07CDFQ39981968-1D85A6EC-AF26-49E5-99F7-BCAD7FF4D569Q40362076-DF57A970-9C61-494B-A24E-FA1D40715079Q40559827-40B25019-E10C-46C1-8B38-5B9259820E11Q41574088-DC5E5875-1E44-4409-B433-BB7892ECC34EQ42180846-1B4DE866-ED8D-4365-8F62-211FEE4C0B2CQ42450828-C4BF0D85-1817-48E6-8B4D-254CA2C0BF53Q46627912-7A6FD65D-A752-4BBD-B086-DB7E3C59C387Q47691032-AD568C9F-0277-4B66-86DB-B2E3F4DF5841Q50955239-26A35B98-2F9A-4B66-BCEB-E2D8BEBE0C77Q51296487-E90BB42A-FB7C-4FFD-865A-66BA984CF774Q51439096-92F96C9A-9688-41CB-AEF3-C06DBCEE2AC4Q51506172-4E90405C-FC7B-4A3B-832A-30DFB85B6F38Q52884352-95A20C15-984F-49BD-AB47-2F2D43E0EF46Q54446441-1796CE37-71F4-4A6F-BEC1-49E748F47471
P2860
Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Selective attenuation of metab ...... epatoma cell line, HepG2 cells
@ast
Selective attenuation of metab ...... epatoma cell line, HepG2 cells
@en
Selective attenuation of metab ...... epatoma cell line, HepG2 cells
@nl
type
label
Selective attenuation of metab ...... epatoma cell line, HepG2 cells
@ast
Selective attenuation of metab ...... epatoma cell line, HepG2 cells
@en
Selective attenuation of metab ...... epatoma cell line, HepG2 cells
@nl
prefLabel
Selective attenuation of metab ...... epatoma cell line, HepG2 cells
@ast
Selective attenuation of metab ...... epatoma cell line, HepG2 cells
@en
Selective attenuation of metab ...... epatoma cell line, HepG2 cells
@nl
P2093
P2860
P356
P1476
Selective attenuation of metab ...... epatoma cell line, HepG2 cells
@en
P2093
K Hashizume
K Nakajima
K Yamauchi
S Shigematsu
P2860
P304
P356
10.1074/JBC.M905410199
P407
P577
2000-07-07T00:00:00Z